5 months ago

tech.eu

Cate Lawrence

Insempra secures $20M Series A to advance bio-based alternatives in manufacturing

German biotech Insempra has successfully completed a $20 million Series A financing round. Insempra enables businesse...

• Insempra
• EQT Ventures
• blueyard capital
• Possible Ventures